S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Summit Therapeutics (SMMT) Insider Trading & Ownership

$3.50
-0.01 (-0.28%)
(As of 04/19/2024 ET)

Summit Therapeutics (NASDAQ:SMMT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
83.70%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$5.54 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get SMMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Summit Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMMT Insider Buying and Selling by Quarter

Summit Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/26/2024Ankur DhingraCFOBuy100,000$3.75$375,000.00  
3/26/2024Mahkam ZanganehCEOBuy30,000$3.75$112,500.00  
12/13/2023Ankur DhingraCFOBuy20,400$2.17$44,268.00  
12/12/2023Mahkam ZanganehCEOBuy5,000$2.07$10,350.00  
10/13/2023Manmeet Singh SoniCOOBuy2,976,190$1.68$4,999,999.20  
(Data available from 1/1/2013 forward)

SMMT Insider Trading Activity - Frequently Asked Questions

Who is on Summit Therapeutics's Insider Roster?

The list of insiders at Summit Therapeutics includes Ankur Dhingra, Mahkam Zanganeh, Maky Zanganeh, Manmeet Singh Soni, and Robert W Duggan. Learn more on insiders at SMMT.

What percentage of Summit Therapeutics stock is owned by insiders?

83.70% of Summit Therapeutics stock is owned by insiders. Learn more on SMMT's insider holdings.

Which Summit Therapeutics insiders have been buying company stock?

The following insiders have purchased SMMT shares in the last 24 months: Ankur Dhingra ($636,658.39), Mahkam Zanganeh ($16,895,280.15), Manmeet Singh Soni ($4,999,999.20), and Robert W Duggan ($487,318,100.91).

How much insider buying is happening at Summit Therapeutics?

Insiders have purchased a total of 490,652,335 SMMT shares in the last 24 months for a total of $509,850,038.65 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:SMMT) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners